共 197 条
[21]
van Waarde A(2002)Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma Ann Oncol 13 1356-1903
[22]
Cobben DC(2010)Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma J Clin Oncol 28 1896-318
[23]
Suurmeijer AJ(2009)High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens Ann Oncol 20 309-1695
[24]
Maas B(2010)Dose–response relationship in cyclophosphamide-treated B-cell lymphoma xenografts monitored with [18F]FDG PET Eur J Nucl Med Mol Imaging 37 1688-238
[25]
Vaalburg W(1986)Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution J Nucl Med 27 235-468
[26]
Shields AF(2011)Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial Lancet Oncol 12 460-674
[27]
Mankoff DA(2011)Hallmarks of cancer: the next generation Cell 144 646-200
[28]
Link JM(2002)DNA and its associated processes as targets for cancer therapy Nat Rev Cancer 2 188-177
[29]
Graham MM(1998)SCID mouse models of human stem cell engraftment Stem Cells 16 166-688
[30]
Eary JF(2003)[(18)F]FDG-PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging 30 682-1980